Form 8-K - Current report:
SEC Accession No. 0001641172-25-009247
Filing Date
2025-05-08
Accepted
2025-05-08 16:05:12
Documents
18
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 47239
2 EX-99.1 ex99-1.htm EX-99.1 93175
3 EX-99.2 ex99-2.htm EX-99.2 136776
4 GRAPHIC ex99-1_001.jpg GRAPHIC 9797
5 GRAPHIC ex99-2_001.jpg GRAPHIC 4893
  Complete submission text file 0001641172-25-009247.txt   556047

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20250508.xsd EX-101.SCH 3944
7 XBRL DEFINITION FILE hrow-20250508_def.xml EX-101.DEF 26962
8 XBRL LABEL FILE hrow-20250508_lab.xml EX-101.LAB 37183
9 XBRL PRESENTATION FILE hrow-20250508_pre.xml EX-101.PRE 25582
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6655
Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 25925910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)